Agenda

Please click here to download the detailed agenda for the 2nd European Iron Academy.

Participants will attend four different breakout sessions (two on Day 1 and two on Day 2), which they will choose from a selection of ten possible sessions. Please click here to download the learning objectives for each of the sessions.

Thursday 26th March 2015

   TIME TOPIC SPEAKER(S)
08:00 onwards Registration
11:00 – 12:15 Buffet lunch
12:15 – 14:45 Plenary Session  
12:15 – 12:25 Welcome & introduction P. Cacoub and
S. Keshav
12:25 – 13:00 Global burden of anaemia and ID(A)

  • Epidemiology (global prevalence and trends)
  • Disease burden in specific populations
  • Aetiology of ID(A) – the global picture
N. Kassebaum
Physical symptoms and diagnosis P. Cacoub
 13:00 – 13:25 Introduction to iron metabolism and clinical picture of ID(A) I. Macdougall
 13:25 – 13:40 Panel discussion / Q&A
13:40 – 14:30 New data in iron trials – what does this mean for patients? S. Anker
(moderator)
  • Pregnancy
C. Breymann
  • Chronic heart Failure (CHF)
P. Ponikowski
  • Chronic Kidney Disease (CKD)
I. Macdougall
  14:30 – 14:45 Panel discussion / Q&A
  14:45 – 15:15 Coffee Break
 15:15 – 16:30 Interactive Breakout Sessions (1 & 2)  
15:15 – 16:30 Cardiology S. Anker and
D. van Veldhuisen
  • Epidemiology of ID(A) in patients with HF
  • Key data for IV iron in patients with HF
  • Interactive case studies
 15:15 – 16:30 Gastroenterology S. Keshav and
L. Peyrin-Biroulet
  • Pathogenesis of ID in gastrointestinal disorders (IBD, Crohn’s disease, coeliac disease) and impact on clinical outcome / patient QoL
  • Overview of diagnostic guidelines
  • Interactive case studies
 15:15 – 16:30 ID in surgery S. Lasocki
and
T. Richards
  • Perioperative management of ID(A)
  • Importance of patient blood management
  • Clinical cases to discuss management of ID(A) in different types of surgery
15:15 – 16:30 Nephrology J. Mayszko
and A. Stack
  • Pathogenesis of ID(A) in CKD patients
  • Diagnostic challenges in CKD – which markers to measure?
  • Interactive case studies
15:15 – 16:30 Pharmacoeconomics of iron therapy L. Mantovani
and
P. Blank
  • Cost to society: what is the true impact of ID?
  • Benefits of treatment (country-specific case studies)
16:30 – 16:45 Delegates rotate to next parallel session
16:45 – 18:00 Cardiology/renal C. Gaillard
and
P. Ponikowski
  • Impact of ID(A) in patients with cardio-renal anaemia/ID syndrome
  • Clinical data for iron therapy in heart failure or CKD
  • Interactive case studies (diagnosis/management of ID in patients with CKD and heart failure)
16:45 – 18:00 Haematology and oncology N. Kassebaum
and
Y. Beguin
  • Diagnosis/management of ID in cancer patients
  • Patient blood management / transfusion avoidance
  • Interactive case studies
16:45 – 18:00 ID in the elderly P. Cacoub
and
P. Chassagne
  • Pathophysiology of ID(A) in the elderly and impact on health or wellbeing
  • Challenges of diagnosis
  • Interactive case studies to discuss diagnosis/management of ID in specific patient populations
16:45 – 18:00 Optimal dosing and monitoring of IV iron therapy I. Macdougall
and
C. Gasche
  • Overview of available data for IV iron therapy (including children, pregnant women)
  • Guidelines for monitoring iron parameters in patients receiving IV therapy
16:45 – 18:00 Postpartum and heavy menstrual bleeding C. Breymann
and
L. Bahamondes
  • Pathogenesis of ID(A) in women
  • Signs/symptoms and diagnostic work-up of different patient types
  • Interactive case studies
19:00 Meet in the lobby for transfer to dinner
19:30 – 22:00 Dinner

Friday 27th March 2015

   TIME TOPIC SPEAKER(S)
08:00 – 11:00 Interactive Breakout Sessions (3 & 4)*
08:00 – 09:15 Cardiology*  S. Anker and
D. van Veldhuisen
08:00 – 09:15 Gastroenterology*  L. Peyrin-Biroulet
and S. Keshav
08:00 – 09:15 Haematology and oncology* N. Kassebaum and
Y. Beguin
08:00 – 09:15 Nephrology* J. Mayszko and
A. Stack
08:00 – 09:15 Pharmacoeconomics of iron therapy* L. Mantovani
and P. Blank
09:15 – 09:45 Coffee break / delegates rotate to next parallel session
09:45 – 11:00 Cardiology/renal* C. Gaillard and
P. Ponikowski
09:45 – 11:00 ID in the elderly* P. Cacoub and
P. Chassagne
09:45 – 11:00 ID in surgery* S. Lasocki
and T. Richards
09:45 – 11:00 Optimal dosing and monitoring of IV iron therapy* C. Gasche and
I. Macdougall
09:45 – 11:00 Postpartum and heavy menstrual bleeding* C. Breymann and
L. Bahamondes
11:00 – 11.15 Delegates move to plenary room
11:15 – 12:45 Plenary Session  
11:15 – 11:30 Health economics and ID P. Blank
11:30 – 11:50 Monitoring patients and maintenance therapy C. Gasche
11:50 – 12:10 IV iron preparations and safety I. Macdougall
12:10 – 12:40 Panel discussion and review of meeting highlights S. Keshav
(moderator)
12:40 – 12:45 Meeting summary and close P. Cacoub
From 12:45 Buffet lunch and departures

*Breakout sessions on Day 2 are a repeat of those on Day 1. Participants will attend a total of four
different breakout sessions (two on Day 1 and two on Day 2), chosen from the ten sessions available.
CHF, chronic heart failure; CKD, chronic kidney disease; HF, heart failure; IBD, inflammatory bowel
disease; IV: intravenous; ID(A), iron deficiency (anaemia); Q&A, question and answer; QoL, quality of life.